Join to View Full Profile
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215
Phone+1 617-632-3000
Dr. Parry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2016 - 2020
Johns Hopkins UniversityResidency, Internal Medicine, 2013 - 2016- Johns Hopkins University School of MedicineClass of 2013
Certifications & Licensure
MA State Medical License 2016 - 2026
VT State Medical License 2022 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Characteristics and Outcomes of Patients with Double Refractory and Double Exposed Chronic Lymphocytic Leukemia.James T Yoon, Yinglu Zhou, Mariia Mikhaleva, Daniel Sungchul Choi, Stacey M Fernandes
Blood Advances. 2025-04-03 - Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.Adam S Kittai, Ying Huang, Sarah Miller, John N Allan, Seema A Bhat
Blood Cancer Journal. 2025-02-20 - 2 citationsA real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma.Andrew Looka, David A Qualls, Daniel Matthews, Robert A Redd, Christopher Sakellis
Blood Advances. 2025-02-11
Press Mentions
Mapping Genetic Evolution from CLL to Richter’s SyndromeJanuary 10th, 2023- Scientists Map Genetic Evolution of Chronic Lymphocytic Leukemia to Richter’s SyndromeDecember 11th, 2022
- Advances in Malignant Lymphoma: Discoveries from Precursors to ProgressionJune 20th, 2022
- Join now to see all
Grant Support
- Tracing the Evolution of Chronic Lymphocytic Leukemia to Richter's Syndrome: Defining TransformationDANA-FARBER CANCER INST2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
